- Details
- Description
-
Packaging Size1 bottle
-
Strength60mg
-
CompositonCarfilzomib
-
TreatmentＭultiple myeloma
-
FormInjection
-
Brand佑安然®
-
Quantity Unit60mg*1Box
-
ManufacturerQilu pharma,china
Carfilzomib is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. It was developed by Onyx Pharmaceuticals.
Carfilzomib is a prescription medication used to treat adult patients with relapsed or refractory multiple myeloma who have received one to three previous treatments for multiple myeloma in combination with:
- Lenalidomide (Revlimid) and dexamethasone; or
- Dexamethasone; or
- Daratumumab (Darzalex) and dexamethasone; or
- Daratumumab and hyaluronidase-fihj (Darzalex Faspro) and dexamethasone
Carfilzomib is also approved for use as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
